Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease
worldwide, with an estimated prevalence of up to 30% in the general population and higher …

Ultrasound (US) imaging is the most commonly performed cross-sectional diagnostic
imaging modality in the practice of medicine. It is low-cost, non-ionizing, portable, and …

Purpose The nonalcoholic fatty liver disease is the most common liver abnormality. Up to
date, liver biopsy is the reference standard for direct liver steatosis quantification in hepatic …

Quantitative imaging biomarkers of liver disease measured by using MRI and US are
emerging as important clinical tools in the management of patients with chronic liver disease …

Nonalcoholic fatty liver disease is a major global health concern with increasing prevalence,
associated with obesity and metabolic syndrome. Recently, quantitative ultrasound-based …

Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide. The
prevalence in patients with type 2 diabetes mellitus is between 55–80%. The spectrum of …

Hepatic steatosis without specific causes (eg, viral infection, alcohol abuse, etc.) is called
non-alcoholic fatty liver disease (NAFLD), which ranges from non-alcoholic fatty liver (NAFL) …

Nonalcoholic fatty liver disease (NAFLD) is believed to affect one-third of American adults.
Noninvasive methods that enable detection and monitoring of NAFLD have the potential for …

Fatty liver disease has a high and increasing prevalence worldwide, is associated with
adverse cardiovascular events and higher long-term medical costs, and may lead to liver …

Excessive liver fat (steatosis) is now the most common cause of chronic liver disease
worldwide and is an independent risk factor for cirrhosis and associated complications …